Loading: 100%
MASIMO CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 3,050 (as per Q1 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker MASIno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17406080100120
datesClosing price (adj.)
13.10.201785.01
11.10.201785.17
04.10.201786.60
27.09.201785.63
20.09.201785.77
13.09.201785.56
06.09.201786.19
30.08.201783.25
23.08.201784.48
16.08.201786.45
09.08.201784.05
02.08.201796.08
26.07.201796.86
19.07.201796.07
12.07.201792.91
05.07.201791.59
27.06.201792.40
20.06.201792.88
13.06.201790.88
06.06.201789.09
30.05.201787.01
23.05.201785.83
16.05.201785.63
09.05.201785.70
02.05.2017103.42
25.04.201799.90
18.04.201793.99
11.04.201794.50
04.04.201793.62
28.03.201793.54
21.03.201792.21
14.03.201795.81
07.03.201794.32
28.02.201790.36
21.02.201785.32
14.02.201776.99
07.02.201776.19
31.01.201773.58
24.01.201771.68
17.01.201771.57
10.01.201770.64
03.01.201767.40
27.12.201667.85
19.12.201666.53
12.12.201664.80
05.12.201662.13
28.11.201661.77
21.11.201661.99
14.11.201660.41
07.11.201660.47
31.10.201655.00
24.10.201659.57
17.10.201658.89
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
85.01n/a
Market Capitalisation
in million USD
4,348n/a
Enterprise Value
in million USD
4,401n/a
Common Shares Outstanding
as per Apr 1, 2017
51,143,638n/a
Preferred Shares Outstanding
as per Apr 1, 2017
n/a
Average Basic Shares Outstanding
TTM
49,837,000n/a
Average Diluted Shares Outstanding
TTM
54,090,000n/a
Index Membership
n/a
Business Summary
Masimo Corp is a medical technology company. The Company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring.
no data available
Key Financials & Ratios (all figures TTM as per Dec 31, 2016, million USD, full statements further below)
Profit & Loss
Revenues 630n/a
Gross Profit 410n/a
Operating Income 101n/a
EBITDA 0n/a
Net Profit 83n/a
Balance Sheet
Cash and Cash Equivalents 132n/a
Receivables 81n/a
Total Current Assets 299n/a
PP&E 132n/a
Total Assets 602n/a
Accounts Payable 26n/a
Current Debt 0n/a
Total Current Liabilities 133n/a
Long-Term Debt 185n/a
Total Liabilities 326n/a
Total Equity 276n/a
Cash Flow
Depreciation & Amortisation 14n/a
Change in Working Capital -10n/a
Operating Cash Flow 125n/a
Net Change in PP&E and Intangibles -67n/a
Investing Cash Flow -53n/a
Dividends Paid 0n/a
Financing Cash Flow -8n/a
Total Change in Cash 61n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 65.1%n/a
Operating Margin 16.0%n/a
Net Profit Margin 12.9%n/a
Return on Equity 29.6%n/a
Return on Assets 13.5%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales 6.98n/a
Book to Market Value 0.06n/a
Other Ratios
Current Ratio 225.5%n/a
Liabilities to Equity Ratio 118.3%n/a
Debt to Assets Ratio 30.8%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
307
349
439
493
493
547
587
630
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-89
-100
-145
-167
-167
-188
-196
-220
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
218
249
294
326
326
359
391
410
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-146
-166
-208
-241
-241
-271
-298
-309
Selling, General & Administrative
-120
-135
-169
-194
-194
-215
-241
-253
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-25
-32
-38
-47
-47
-56
-57
-57
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
72
83
87
85
85
88
93
101
Non-Operating Income (Loss)
1
0
0
-1
-1
-4
-1
-4
Interest Expense, net
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
1
0
0
-1
-1
-4
-1
-4
Pretax Income (Loss), Adjusted
73
82
87
84
84
84
92
97
Abnormal Gains (Losses)
-1
0
0
0
0
-8
10
20
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
72
82
87
84
84
76
102
116
Income Tax (Expense) Benefit, net
-40
-28
-22
-22
-22
-20
-28
-35
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
32
54
64
62
62
56
74
82
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
32
54
64
62
62
56
74
82
Minority Interest
0
-1
0
0
0
3
-2
2
Net Income
32
53
64
62
62
58
73
83
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
32
53
64
62
62
58
73
83
Remarks
restated on Feb 16, 2011 n/a
calculated values,
restated on Feb 17, 2012 n/a
calculated values,
restated on Feb 14, 2014 n/a
calculated values,
restated on Feb 14, 2014 n/a
calculated values,
restated on Feb 17, 2015 n/a
calculated values,
restated on Feb 15, 2017 n/a
calculated values,
restated on Feb 15, 2017 n/a
calculated values,
restated on Feb 15, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
189
130
72
95
95
134
132
Cash & Cash Equivalents
n/a
132
130
72
95
95
134
132
Short Term Investments
n/a
57
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
50
64
75
84
77
71
81
Accounts Receivable, Net
n/a
39
57
68
77
77
71
81
Notes Receivable, Net
n/a
12
7
7
7
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
32
46
47
57
57
70
62
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
18
23
25
35
43
22
24
Prepaid Expenses
n/a
4
6
7
9
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
12
12
13
20
20
0
0
Income Taxes Receivable
n/a
2
3
2
4
4
0
2
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
1
2
4
3
19
21
21
Total Current Assets
n/a
289
263
219
272
272
297
299
Property, Plant & Equipment, Net
n/a
12
15
24
25
25
102
132
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
55
88
131
142
142
166
170
Intangible Assets
n/a
10
11
27
28
28
28
28
Goodwill
n/a
0
0
23
23
23
21
20
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
12
17
21
23
23
42
44
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
33
59
60
69
69
75
78
Total Noncurrent Assets
n/a
67
103
155
167
167
268
303
Total Assets
n/a
356
366
375
439
439
565
602
Liabilities and owners' equity
Payables & Accruals
n/a
45 44740000
60 59886000
70 70206000
83 82924000
83 82924000
103 102748000
111 111279000
Accounts Payable
n/a
17 16716000
27 27302000
27 27033000
28 28004000
28 28004000
38 38045000
26 25865000
Accrued Taxes
n/a
0 477000
1 570000
2 1504000
2 2406000
2 2406000
7 6562000
3 2777000
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
28 27547000
32 32014000
42 41669000
53 52514000
53 52514000
58 58141000
83 82637000
Short Term Debt
n/a
0 60000
0 48000
0 55000
0 111000
0 111000
0 79000
0 74000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
15 14641000
16 16019000
19 19278000
21 20755000
21 20755000
21 21067000
21 21280000
Deferred Revenue
n/a
15 14641000
16 16019000
19 19278000
21 20755000
21 20755000
21 21067000
21 21280000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
59 59441000
76 75953000
90 89539000
104 103790000
104 103790000
124 123894000
133 132633000
Long Term Debt
n/a
0 171000
0 74000
0 60000
0 225000
0 225000
125 125145000
185 185071000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
7 7045000
10 10411000
9 9394000
8 8246000
8 8246000
8 8226000
8 8319000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 270000
1 984000
1 576000
1 566000
1 566000
0 453000
0 298000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
7 6775000
9 9427000
9 8818000
8 7680000
8 7680000
8 7773000
8 8021000
Total Noncurrent Liabilities
n/a
7 7216000
10 10485000
9 9454000
8 8471000
8 8471000
133 133371000
193 193390000
Total Liabilities
n/a
67 66657000
86 86438000
99 98993000
112 112261000
112 112261000
257 257265000
326 326023000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
196 195748000
244 243586000
259 258840000
273 273186000
273 273186000
289 288738000
332 332467000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-1 -1209000
-37 -37396000
-64 -63664000
-83 -83454000
-83 -83454000
-186 -185906000
-341 -340873000
Retained Earnings
n/a
94 94112000
69 69364000
74 74361000
133 132742000
133 132742000
205 205260000
289 288560000
Other Equity
n/a
0 63000
1 1274000
4 3542000
4 3995000
4 3995000
-2 -2093000
-5 -4739000
Equity Before Minority Interest
n/a
289 288714000
277 276828000
273 273079000
326 326469000
326 326469000
306 305999000
275 275415000
Minority Interest
n/a
1 974000
3 2838000
3 2589000
0 -68000
0 -68000
2 1742000
0 297000
Total Equity
n/a
290 289688000
280 279666000
276 275668000
326 326401000
326 326401000
308 307741000
276 275712000
Total Liabilities & Equity
n/a
356 356345000
366 366104000
375 374661000
439 438662000
439 438662000
565 565006000
602 601735000
Remarks restated on n/a restated on Feb 16, 2011 n/a restated on Feb 15, 2013 n/a restated on Feb 14, 2014 n/a restated on Feb 14, 2014 n/a restated on Feb 17, 2015 n/a restated on Feb 15, 2017 n/a restated on May 4, 2017 n/a
Cash Flow StatementCF data quality: 90% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
32
54
64
62
62
56
74
82
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
6
6
7
9
9
11
13
16
Non-Cash Items
25
11
12
8
8
7
13
9
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
15
-24
-5
-4
-4
-19
-4
8
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
78
47
79
75
75
55
96
114
Change in Fixed Assets & Intangibles
-9
-5
-8
-14
-14
-14
-79
-55
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
-2
0
-37
-37
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
0
-57
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-9
-64
-8
-52
-52
-14
-79
-55
Dividends Paid
0
0
0
-57
-57
0
0
0
Cash From (Repayment of) Debt
-30
0
0
0
0
0
125
200
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
10
3
-30
-25
-25
-17
-98
-122
Increase in Capital Stock
10
3
6
2
2
3
5
28
Decrease in Capital Stock
0
0
-36
-26
-26
-20
-102
-150
Other Financing Activities
2
0
0
0
0
-1
-1
3
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
-19
2
-30
-82
-82
-18
26
81
Net Cash Before Disc. Operations and FX
50
-15
41
-59
-59
23
43
141
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
50
-15
41
-59
-59
23
43
141
Effect of Foreign Exchange Rates
0
0
0
0
0
1
-4
-3
Net Changes in Cash
50
-15
42
-58
-58
24
39
138
Remarks
restated on Feb 16, 2011 n/a
calculated values,
restated on Feb 17, 2012 n/a
calculated values,
restated on Feb 14, 2014 n/a
calculated values,
restated on Feb 14, 2014 n/a
calculated values,
restated on Feb 17, 2015 n/a
calculated values,
restated on Feb 15, 2017 n/a
calculated values,
restated on Feb 15, 2017 n/a
calculated values,
restated on Feb 15, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo